Hatchtech Pty Ltd to explore strategic alternatives for commercialization of Xeglyze™ lotion in the U.S.

chevron_leftPreviosly
OneVentures appoints new Venture Partner
07 May 2015
Nextchevron_right
Vaxxas Nanopatch on Channel 7 News and Today Tonight
23 February 2015

You may also like

13 August 2018

OneVentures invests in regional Queensland company developing treatments for autoimmune diseases

04 September 2017

Citadel Group aquires OneVentures portfolio company Charm Health

14 October 2021

Blade Therapeutics Announces FDA Orphan Drug Designation Granted to Cudetaxestat for Treatment of Systemic Sclerosis

27 November 2012

Hatchtech publish data on Head Lice treatment safety study and mechanism of action

17 June 2019

Leading Airbnb Property Management Company, Hometime, announces $6M funding round with OneVentures, in inaugural venture debt deal

31 August 2021

OneVentures takes VC industry lead on ESG investment and oversight

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor